Main navigation
What We Do
What We Do
Investment Banking
Public Finance
Research
Fixed Income
Alternative Asset Management
Equities
Sectors
Sectors
Chemicals
Consumer
Education
Energy, Power & Infrastructure
Financial Services
Financial Sponsors
Government
Healthcare
Real Estate
Services & Industrials
Technology
About
About
Who We Are
Our Commitments
Our People
News & Insights
Conferences & Events
Careers
Investor Relations
Transactions
Transactions
Investment Banking
Public Finance
Contact
Search
Invalid search inquiry
Log In
Log In
Client Account Access
Fixed Income Client Portal
Merchant Banking Investor Access
Research Access
Read more
about Pliant-2023-01-24
$287.5 Million
Image
Pliant Therapeutics, Inc.
Follow-On Offering
Active Bookrunner
Read more
about CymaBay-2022-01-23
$97.7 Million
Image
CymaBay Therapeutics, Inc.
Confidentially Marketed Follow-On Offering
Left Bookrunner
Read more
about FulcrumTherapeutics-2023-01-17
$125.0 Million
Image
Fulcrum Therapeutics, Inc.
Confidentially Marketed Follow-On Offering
Active Bookrunner
Read more
about KaryopharmTherapeutics-2022-12-05
$165.0 Million
Image
Karyopharm Therapeutics, Inc.
PIPE
Left Bookrunner
Read more
about X4Pharmaceuticals-2022-12-07
$65.0 Million
Image
X4 Pharmaceuticals Inc.
Follow-On Offering
Left Bookrunner
Read more
about Replimune-2022-12-08
$258.8 Million
Image
Replimune Group, Inc.
Follow-On Offering
Active Bookrunner
Read more
about ImmunityBio-2022-12-01
$50.0 Million
Image
ImmunityBio
Registered Direct
Sole Placement Agent
BioInsights Report - Gene Editing: The Next Revolution in Precision Medicine
Read more
about CXLOphthalmics-2022-09-30
$32.0 Million
Image
CXL Ophthalmics, LLC
Minority Capital Raise
Financial Advisor
Read more
about VectivBio-2022-10-13
$125.3 Million
Image
VectivBio
Registered Direct
Active Bookrunner
Pagination
Previous page
‹‹
Page 13
Next page
››
Subscribe to Biopharma
